Table 4. Network meta-analysis results of esophageal cancer treatments.
| (a) 3-year Overall Survival | |||
| S | 0.94 (0.89, 1.00) | 1.08 (0.99, 1.18) | 0.80 (0.74, 0.87) |
| 1.06 (1.00, 1.13) | CT+S | 1.14 (1.02, 1.28) | 0.85 (0.77, 0.94) |
| 0.93 (0.84, 1.02) | 0.87 (0.78, 0.98) | RT+S | 0.74 (0.66, 0.84) |
| 1.25 (1.15, 1.35) | 1.18 (1.07, 1.30) | 1.35 (1.19, 1.52) | CRT+S |
| (b) 5-year Overall Survival | |||
| S | 0.90 (0.85, 0.95) | 1.10 (1.01, 1.19) | 0.75 (0.70, 0.81) |
| 1.11 (1.05, 1.18) | CT+S | 1.22 (1.10, 1.35) | 0.84 (0.77, 0.92) |
| 0.91 (0.84, 0.99) | 0.82 (0.74, 0.91) | RT+S | 0.69 (0.62, 0.77) |
| 1.33 (1.23, 1.43) | 1.19 (1.09, 1.30) | 1.45 (1.30, 1.62) | CRT+S |
| (c) Disease-free Survival | |||
| S | 0.81 (0.74, 0.88) | - | 0.70 (0.65, 0.76) |
| 1.24 (1.13, 1.36) | CT+S | - | 0.87 (0.78, 0.97) |
| - | - | RT+S | - |
| 1.43 (1.32, 1.54) | 1.15 (1.03, 1.29) | - | CRT+S |
| (d) Recurrence | |||
| S | 0.70 (0.29, 1.64) | - | 0.34 (0.11, 0.92) |
| 1.43 (0.61, 3.46) | CT+S | - | 0.49 (0.14, 1.58) |
| - | - | RT+S | - |
| 2.95 (1.08, 8.79) | 2.05 (0.63, 7.19) | - | CRT+S |
| (e) Metastasis | |||
| S | 0.82 (0.55, 1.15) | - | 0.72 (0.44, 1.12) |
| 1.22 (0.87, 1.82) | CT+S | - | 0.89 (0.48, 1.62) |
| - | - | RT+S | - |
| 1.38 (0.89, 2.25) | 1.12 (0.62, 2.08) | - | CRT+S |
Abbreviation: CRT-chemoradiotherapy, S-surgery, CT-chemotherapy, RT-radiotherapy.
Note: In the overall survival of 3 years and 5 years and the disease-free survival, the data are presented in HR (hazard ratio) and 95% CrI. In the results of reccurence and matastasis, the data are presented in OR (odds ratio) and 95% CrI.